Evaluation of the Therapeutic Effect of Curcumin-Conjugated Zinc Oxide Nanoparticles on Reserpine-Induced Depression in Wistar Rats
- PMID: 37713054
- PMCID: PMC11052778
- DOI: 10.1007/s12011-023-03849-z
Evaluation of the Therapeutic Effect of Curcumin-Conjugated Zinc Oxide Nanoparticles on Reserpine-Induced Depression in Wistar Rats
Abstract
Depression, a devastating brain illness, necessitates the exploration of novel antidepressant treatments. We evaluated the antidepressant effects of free curcumin, zinc oxide nanoparticles (ZnO NPs), and curcumin-conjugated zinc oxide nanoparticles (Zn(cur)O NPs). The nanoformulations were extensively characterized using advanced techniques. An acute toxicity study ensured the safety of Zn(cur)O NPs. Rats were assigned to one of five groups: control, reserpine-induced depression model, treatment with ZnO NPs, free curcumin, or Zn(cur)O NPs. Behavioral assessments (forced swimming test [FST] and open-field test [OFT]) and neurochemical analyses were conducted. Zn(cur)O NPs exhibited superior efficacy in ameliorating reserpine-induced behavioral and neurochemical effects compared to free curcumin and ZnO NPs. The reserpine-induced model displayed reduced motor activity, swimming time, and increased immobility time in the FST and OFT. Treatment with Zn(cur)O NPs 45 mg/kg significantly improved motor activity and reduced immobility time. Furthermore, Zn(cur)O NPs decreased malondialdehyde (MDA) levels while increasing reduced glutathione (GSH) and catalase (CAT) levels. Additionally, concentrations of serotonin (5-HT) and norepinephrine (NE) increased. In conclusion, curcumin-conjugated zinc oxide nanoparticles demonstrate potent antidepressant effects, alleviating depressive-like behavior in rats. These findings support Zn(cur)O NPs as a promising therapeutic strategy for depression management, warranting further investigation and clinical validation.
Keywords: Curcumin; Depression; Monoamines; Reserpine; Zinc oxide nanoparticles.
© 2023. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures











Similar articles
-
Antidepressant effects of curcumin-coated iron oxide nanoparticles in a rat model of depression.Eur J Pharmacol. 2021 Oct 5;908:174384. doi: 10.1016/j.ejphar.2021.174384. Epub 2021 Jul 27. Eur J Pharmacol. 2021. PMID: 34324858
-
Thymoquinone-encapsulated chitosan nanoparticles coated with polysorbate 80 as a novel treatment agent in a reserpine-induced depression animal model.Physiol Behav. 2020 Aug 1;222:112934. doi: 10.1016/j.physbeh.2020.112934. Epub 2020 Apr 27. Physiol Behav. 2020. PMID: 32353367
-
Electrocortical and Biochemical Evaluation of Antidepressant Efficacy of Formulated Nanocurcumin.Appl Biochem Biotechnol. 2019 Mar;187(3):1096-1112. doi: 10.1007/s12010-018-2866-4. Epub 2018 Aug 31. Appl Biochem Biotechnol. 2019. PMID: 30167967
-
The effect of curcumin on reserpine-induced depression-like behaviour in rats.Psychiatry Res Neuroimaging. 2023 Sep;334:111682. doi: 10.1016/j.pscychresns.2023.111682. Epub 2023 Jul 20. Psychiatry Res Neuroimaging. 2023. PMID: 37506423
-
Prospects of Curcumin Nanoformulations in Cancer Management.Molecules. 2022 Jan 7;27(2):361. doi: 10.3390/molecules27020361. Molecules. 2022. PMID: 35056675 Free PMC article. Review.
Cited by
-
The Dynamic Role of Curcumin in Mitigating Human Illnesses: Recent Advances in Therapeutic Applications.Pharmaceuticals (Basel). 2024 Dec 11;17(12):1674. doi: 10.3390/ph17121674. Pharmaceuticals (Basel). 2024. PMID: 39770516 Free PMC article. Review.
-
Combating Lead/HFD Neurotoxicity in Rats: The Synergistic Effect of 10-Hydroxydecanoic Acid and Zinc Oxide Nanoparticles.Biol Trace Elem Res. 2025 Aug 20. doi: 10.1007/s12011-025-04764-1. Online ahead of print. Biol Trace Elem Res. 2025. PMID: 40836190
-
Nanocarrier drug delivery system: promising platform for targeted depression therapy.Front Pharmacol. 2024 Jul 25;15:1435133. doi: 10.3389/fphar.2024.1435133. eCollection 2024. Front Pharmacol. 2024. PMID: 39119603 Free PMC article. Review.
-
Nanotechnology-driven therapies for neurodegenerative diseases: a comprehensive review.Ther Deliv. 2024;15(12):997-1024. doi: 10.1080/20415990.2024.2401307. Epub 2024 Sep 19. Ther Deliv. 2024. PMID: 39297726 Review.
-
Advances of curcumin in nervous system diseases: the effect of regulating oxidative stress and clinical studies.Front Pharmacol. 2024 Nov 1;15:1496661. doi: 10.3389/fphar.2024.1496661. eCollection 2024. Front Pharmacol. 2024. PMID: 39555102 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous